Will Karyopharm (KPTI) Continue to Surge Higher? - Tale of the Tape

By Zacks Equity Research,

Shutterstock photo

As of late, it has definitely been a great time to be an investor in Karyopharm Therapeutics Inc ( KPTI ) . The stock has moved higher by 51.7% in the past month, while it is also above its 20 Day SMA too. This combination of strong price performance and favorable technical, could suggest that the stock may be on the right path.

We certainly think that this might be the case, particularly if you consider KPTI's recent earnings estimate revision activity. From this look, the company's future is quite favorable; as KPTI has earned itself a Zacks Rank #2 (Buy), meaning that its recent run may continue for a bit longer, and that this isn't the top for the in-focus company.

KARYOPHARM THER (KPTI): Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: Investing , Investing Ideas , Stocks
Referenced Stocks: KPTI

More from Zacks.com




Follow on:

Find a Credit Card

Select a credit card product by:
Select an offer:
Data Provided by BankRate.com